.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
QuintilesIMS
Harvard Business School
Argus Health
Chubb
Daiichi Sankyo
Cerilliant
Chinese Patent Office
US Department of Justice
Cipla

Generated: June 22, 2017

Indonesia Drug Patents

These international patent data are derived from patent families, based on US drug-patent linkages.
They should not be regarded as comprehensive records of ex-US drug-patent associations.

Document Number Estimated Expiration Equivalent US Patent US Expiry Date Generic Name US Applicant US Tradename
29837► Subscribe9358207Apr 12, 2020
aripiprazole
Otsuka
ABILIFY
28675► Subscribe6979463Mar 28, 2022
desloratadine; pseudoephedrine sulfate
Merck Sharp Dohme
CLARINEX D 24 HOUR
30509► Subscribe7802568Feb 26, 2019
olodaterol hydrochloride
Boehringer Ingelheim
STRIVERDI RESPIMAT
30509► Subscribe7802568Feb 26, 2019
albuterol sulfate; ipratropium bromide
Boehringer Ingelheim
COMBIVENT RESPIMAT
30509► Subscribe6988496Feb 23, 2020
olodaterol hydrochloride
Boehringer Ingelheim
STRIVERDI RESPIMAT
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Dow
Cipla
Accenture
Moodys
Cerilliant
Novartis
US Army
Federal Trade Commission
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot